Eliquis

As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
Endpoints
Pfizer
Bristol-Myers Squibb
FDA
generics
bloodthinners
Eliquis
Micro Labs
Mylan
Flag link:
Pfizer, BMS look to early atrial fibrillation screening for potential Eliquis boost
Pfizer, BMS look to early atrial fibrillation screening for potential Eliquis boost
Fierce Pharma
Pfizer
Eliquis
Bristol-Myers Squibb
atrial fibrillation
Flag link:
Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report
Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report
Fierce Pharma
Merck
Keytruda
Bristol-Myers Squibb
Pfizer
Eliquis
AbbVie
Humira
Flag link:
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
Fierce Pharma
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Europe
ESC
European Society of Cardiology
Flag link:
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
Yahoo/Motley Fool
Merck
Keytruda
AbbVie
Humira
Pfizer
Bristol-Myers Squibb
Eliquis
JNJ
Imbruvica
Flag link:
Meet the Top Ten Drugs of 2024 (Maybe)
Meet the Top Ten Drugs of 2024 (Maybe)
Drug Channels
AbbVie
Humira
Merck
Keytruda
Eliquis
Bristol-Myers Squibb
Imbruvica
Opdivo
Revlimid
Celgene
Flag link:
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
Flag link:
J&J snaps up key label expansion for Xarelto
J&J snaps up key label expansion for Xarelto
Biopharma Dive
JNJ
Xarelto
bloodthinners
Eliquis
Janssen
Bayer
Flag link:
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
Fierce Pharma
Pfizer
Bristol-Myers Squibb
JNJ
Eliquis
Xarelto
Warfarin
bloodthinners
Flag link:
How Bristol-Myers and Pfizer are using real-world data to unseat warfarin
How Bristol-Myers and Pfizer are using real-world data to unseat warfarin
Biopharma Dive
Bristol-Myers Squibb
Pfizer
Warfarin
real world evidence
RWE
bloodthinners
Eliquis
Flag link:
Bristol-Myers calls on real-world evidence to unseat warfarin
Bristol-Myers calls on real-world evidence to unseat warfarin
Biopharma Dive
Bristol-Myers Squibb
Warfarin
Eliquis
Pfizer
bloodthinners
Flag link:
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Merck
Keytruda
AbbVie
Humira
Mavyret
Bristol-Myers Squibb
Eliquis
Pfizer
Ibrance
Flag link:
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO
Fierce Pharma
Bristol-Myers Squibb
Eliquis
Pharma CEOs
Giovanni Caforio
Pfizer
JPMHC 2018
Flag link:
Bristol-Myers, Pfizer continue to build case for Eliquis
Bristol-Myers, Pfizer continue to build case for Eliquis
BioPharma Dive
Bristol-Myers Squibb
Pfizer
Eliquis
blood thinners
Flag link:
Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases
Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases
Fierce Pharma
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Flag link:
Bristol-Myers Squibb recalls mislabeled Eliquis medications
Bristol-Myers Squibb recalls mislabeled Eliquis medications
BioPharma Dive
Bristol-Myers Squibb
Eliquis
recalls
labeling
Flag link:
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
Fierce Pharma
Bristol-Myers Squibb
Pfizer
patents
Eliquis
patent lawsuits
generics
bloodthinners
Flag link:
Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin
Bristol-Myers and Pfizer's Eliquis outperforms rivals versus warfarin
BioPharma Dive
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Warfarin
Flag link:
Many at risk for stroke don’t get anti-clotting drugs
Many at risk for stroke don’t get anti-clotting drugs
Reuters
stroke
atrial fibrillation
Pradaxa
Xarelto
Eliquis
bloodthinners
Flag link:
Pfizer's 3 Fastest-Growing Drugs
Pfizer's 3 Fastest-Growing Drugs
Motley Fool
Pfizer
Ibrance
Eliquis
Xeljanz
Flag link:

Pages